Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor

Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor

US Patent 11484592 · Granted Nov 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intranasal epinephrine formulations and methods for the treatment of disease2025
Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a c2024
Intranasal epinephrine formulations and methods for the treatment of disease2024
Intranasal epinephrine formulations and methods for the treatment of disease2023
Intranasal epinephrine formulations and methods for the treatment of disease2023
Intranasal epinephrine formulations and methods for the treatment of disease2021
Antibody that specifically recognizes and binds to REIC/Dkk-3 protein having act2020
Intranasal epinephrine formulations and methods for the treatment of disease2020
Conditionally replicating adenovirus to express REIC gene2018
Partial region polypeptide of REIC/Dkk-3 protein2017
System for increasing gene expression and vector comprising the system2016
Direct administration of REIC/Dkk-3 to mesothelioma2016